Correction to Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes.

Shiliang LiChun QinShichao CuiHongling XuFangshu WuJiawei WangMingbo SuXiaoyu FangDan LiQian JiaoMing ZhangChunmei XiaLili ZhuRui WangJia LiHualiang JiangZhenjiang ZhaoJingya LiHongLin Li

Published in: Journal of medicinal chemistry (2019)

Keyphrases

type diabetes
small molecule
high throughput
cardiovascular disease
glycemic control
cell therapy
stem cells
insulin resistance
combination therapy
mesenchymal stem cells
adipose tissue
weight loss
single cell
smoking cessation